BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11818701)

  • 1. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.
    Leoncini G; Martinoli C; Viazzi F; Ravera M; Parodi D; Ratto E; Vettoretti S; Tomolillo C; Derchi LE; Deferrari G; Pontremoli R
    Nephron; 2002 Feb; 90(2):169-73. PubMed ID: 11818701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term effect of nifedipine GITS and lisinopril on subclinical organ damage in patients with essential hypertension.
    Pontremoli R; Viazzi F; Ravera M; Leoncini G; Berruti V; Bezante GP; Del Sette M; Deferrari G
    J Nephrol; 2001; 14(1):19-26. PubMed ID: 11281339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension].
    Widecka K; Celibała R; Czekalski S
    Pol Arch Med Wewn; 1995 Feb; 93(2):135-42. PubMed ID: 7479231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
    J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
    Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lisinopril and nitrendipine on urinary albumin excretion and renal function in patients with mild to moderate essential hypertension.
    Ogawa Y; Haneda T; Hirayama T; Ide H; Obara A; Maruyama J; Morimoto H; Tanaka H; Kato J; Hayakawa T; Hasebe N; Kikuchi K
    Hypertens Res; 2000 Nov; 23(6):607-12. PubMed ID: 11131273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure.
    Campo C; Garcia-Vallejo O; Barrios V; Lahera V; Manero M; Esteban E; Rodicio JL; Ruilope LM
    J Hypertens; 1997 Dec; 15(12 Pt 2):1803-8. PubMed ID: 9488243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
    Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
    Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study.
    Poulsen PL; Ebbehøj E; Mogensen CE
    J Intern Med; 2001 May; 249(5):433-40. PubMed ID: 11350567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients.
    Taddei S; Omboni S; Ghiadoni L; Caiazza A; Fogari R; Innocenti P; Porcellati C; Giovannetti R; Corradi L; Mancia G; Salvetti A
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):579-85. PubMed ID: 12658059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study.
    Midtvedt K; Ihlen H; Hartmann A; Bryde P; Bjerkely BL; Foss A; Fauchald P; Holdaas H
    Transplantation; 2001 Jul; 72(1):107-11. PubMed ID: 11468543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients.
    Asberg A; Midtvedt K; Vassbotn T; Hartmann A
    Nephrol Dial Transplant; 2001 Jul; 16(7):1465-70. PubMed ID: 11427642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; Raffaele J; Tsalamandris C
    Am J Kidney Dis; 2001 May; 37(5):890-9. PubMed ID: 11325669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril.
    Midtvedt K; Hartmann A; Foss A; Fauchald P; Nordal KP; Rootwelt K; Holdaas H
    Transplantation; 2001 Dec; 72(11):1787-92. PubMed ID: 11740389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist.
    Crepaldi G; Carraro A; Brocco E; Adezati L; Andreani D; Bompiani G; Brunetti P; Fedele D; Giorgino R; Giustina G
    Acta Diabetol; 1995 Oct; 32(3):203-8. PubMed ID: 8590792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of long-term effects of lisinopril vs nifedipine vs conventional therapy in the treatment of mild-to-moderate hypertension in patients with chronic obstructive pulmonary disease.
    Lin M; Yang YF; Lee D; Chiang HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun; 57(6):392-400. PubMed ID: 8803300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria.
    Fogari R; Mugellini A; Zoppi A; Lazzari P; Destro M; Rinaldi A; Preti P
    Eur J Clin Pharmacol; 2005 Aug; 61(7):483-90. PubMed ID: 16021438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.